Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Laetitia Cicchelero, Sofie Denies, Bert Devriendt, Hilde de Rooster & Niek N Sanders. (2015) Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?. OncoImmunology 4:12.
Read now
Read now
Petr G Lokhov & Elena E Balashova. (2015) Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC). Human Vaccines & Immunotherapeutics 11:3, pages 689-698.
Read now
Read now
Laetitia Cicchelero, Hilde de Rooster & Niek N Sanders. (2014) Various ways to improve whole cancer cell vaccines. Expert Review of Vaccines 13:6, pages 721-735.
Read now
Read now
Sanjay Srivatsan, Jaina M Patel, Erica N Bozeman, Imade E Imasuen, Sara He, Danielle Daniels & Periasamy Selvaraj. (2014) Allogeneic tumor cell vaccines. Human Vaccines & Immunotherapeutics 10:1, pages 52-63.
Read now
Read now
Petr G. Lokhov & Elena E. Balashova. (2013) Universal cancer vaccine. Human Vaccines & Immunotherapeutics 9:7, pages 1549-1552.
Read now
Read now
Petr Lokhov & Elena E. Balashova. (2013) Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro. Human Vaccines & Immunotherapeutics 9:1, pages 198-209.
Read now
Read now
Bernadette D’Souza, Tuhin Bhowmik, Rangaiah Shashidharamurthy, Carl Oettinger, Periasamy Selvaraj & Martin D’Souza. (2012) Oral microparticulate vaccine for melanoma using M-cell targeting. Journal of Drug Targeting 20:2, pages 166-173.
Read now
Read now
Julia K. Tietze, Gail D. Sckisel, Hui-Hua Hsiao & William J. Murphy. (2011) Antigen-specific versus Antigen-nonspecific Immunotherapeutic Approaches for Human Melanoma: The Need for Integration for Optimal Efficacy?. International Reviews of Immunology 30:5-6, pages 238-293.
Read now
Read now
Mark Tangney, Sarfraz Ahmad, Sara A. Collins & Gerald C. O'Sullivan. (2010) Gene Therapy for Prostate Cancer. Postgraduate Medicine 122:3, pages 166-180.
Read now
Read now
Vincent G Brichard & Diane Lejeune. (2008) Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease. Expert Opinion on Biological Therapy 8:7, pages 951-968.
Read now
Read now
Leisha A Emens. (2008) Cancer vaccines: on the threshold of success. Expert Opinion on Emerging Drugs 13:2, pages 295-308.
Read now
Read now
Articles from other publishers (74)
Jing Liang, Xiaohui Qiao, Luping Qiu, Huning Xu, Huijing Xiang, Hong Ding & Yu Chen. (2023) Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy. Advanced Science.
Crossref
Crossref
Jiaqi Meng, Yanlin Lv, Weier Bao, Zihui Meng, Shuang Wang, Yuanbin Wu, Shuping Li, Zhouguang Jiao, Zhiyuan Tian, Guanghui Ma & Wei Wei. (2023) Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation. Nature Communications 14:1.
Crossref
Crossref
Yueyi Li, Shen Li, Zedong Jiang, Keqin Tan, Yuanling Meng, Dingyi Zhang & Xuelei Ma. (2023) Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Yang Bo & Hua Wang. (2023) Biomaterial‐Based In Situ Cancer Vaccines. Advanced Materials.
Crossref
Crossref
Mohammad Ejaz & Muhammad Ali Syed. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
21
.
Melissa Anne Tutty, Sarah Holmes & Adriele Prina-Mello. 2023. Cancer Cell Culture. Cancer Cell Culture
3
40
.
Jifeng Yu, Hao Sun, Weijie Cao, Yongping Song & Zhongxing Jiang. (2022) Research progress on dendritic cell vaccines in cancer immunotherapy. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
Huju Chi, Yue Hao, Xia Wang, Li Tang, Yongqiang Deng, Xianxiong Chen, Feng Gao, Ou Sha & Guangyi Jin. (2022) A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist. Cells 11:13, pages 1986.
Crossref
Crossref
Ridhima Jasrotia, Daljeet Singh Dhanjal, Sonali Bhardwaj, Parvarish Sharma, Chirag Chopra, Reena Singh, Anupam Kumar, Anamika Mubayi, Deepak Kumar, Raj Kumar & Abhineet Goyal. (2022) Nanotechnology based vaccines: Cervical cancer management and perspectives. Journal of Drug Delivery Science and Technology 71, pages 103351.
Crossref
Crossref
Zhouqi Meng, Yaojia Zhang, Xuanfang Zhou, Jiansong Ji & Zhuang Liu. (2022) Nanovaccines with cell-derived components for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114107.
Crossref
Crossref
Ming Qin, Guangsheng Du, Nan Qiao, Zhaofei Guo, Min Jiang, Chunting He, Shuting Bai, Penghui He, Yanhua Xu, Hairui Wang, Tao Gong, Zhirong Zhang & Xun Sun. (2021) Whole‐Cell‐Mimicking Carrier‐Free Nanovaccines Amplify Immune Responses Against Cancer and Bacterial Infection. Advanced Functional Materials 32:10.
Crossref
Crossref
Ayusha Dondulkar, Natasha Akojwar, Chanti Katta, Dharmendra K. Khatri, Neelesh K. Mehra, Shashi B. Singh & Jitender Madan. (2022) Inhalable Polymeric Micro and Nano-immunoadjuvants for Developing Therapeutic
Vaccines in the Treatment of Non-small Cell Lung Cancer. Current Pharmaceutical Design 28:5, pages 395-409.
Crossref
Crossref
Mei-Zhen Zou, Zi-Hao Li, Xue-Feng Bai, Chuan-Jun Liu & Xian-Zheng Zhang. (2021) Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy. Nano Letters 21:20, pages 8609-8618.
Crossref
Crossref
Alireza Milani, Azam Bolhassani, Fatemeh Rouhollah & Maryam Naseroleslami. (2021) Which one of the thermal approaches (heating DNA or cells) enhances the gene expression in mammalian cells?. Biotechnology Letters 43:10, pages 1955-1966.
Crossref
Crossref
Jingwei Ma, Huafeng Zhang, Ke Tang & Bo Huang. (2020) Tumor‐derived microparticles in tumor immunology and immunotherapy. European Journal of Immunology 50:11, pages 1653-1662.
Crossref
Crossref
Young Sok Ji, Seong Kyu Park & Seongho Ryu. (2020) Whole leukemia cell vaccines: Past progress and future directions. Vaccine 38:22, pages 3811-3820.
Crossref
Crossref
Sarah Cunningham & Holger Hackstein. (2020) Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells. Transfusion Medicine and Hemotherapy 47:6, pages 454-463.
Crossref
Crossref
Lokhov, Mkrtichyan, Mamikonyan & Balashova. (2019) SANTAVACTM: Summary of Research and Development. Vaccines 7:4, pages 186.
Crossref
Crossref
Junyu Cai, Hao Wang, Dangge Wang & Yaping Li. (2019) Improving Cancer Vaccine Efficiency by Nanomedicine. Advanced Biosystems 3:3.
Crossref
Crossref
Chee Wee Ng, Jingchao Li & Kanyi Pu. (2018) Recent Progresses in Phototherapy-Synergized Cancer Immunotherapy. Advanced Functional Materials 28:46, pages 1804688.
Crossref
Crossref
Chris Weir, Annika Oksa, Jennifer Millar, Miles Alexander, Nicola Kynoch, Zoe Walton-Weitz, Peter Mackenzie-Wood, Felicia Tam, Hope Richards, Richard Naylor, Katrina Cheng, Peter Bennett, Nikolai Petrovsky & Rachel Allavena. (2018) The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients. Veterinary Sciences 5:4, pages 87.
Crossref
Crossref
Jessica Silva, Ana Miranda, João Sousa, Alberto Pais & Carla Vitorino. 2018. Biopharmaceuticals. Biopharmaceuticals.
Jingwei Ma, Keke Wei, Huafeng Zhang, Ke Tang, Fei Li, Tianzhen Zhang, Junwei Liu, Pingwei Xu, Yuandong Yu, Weiwei Sun, LiYan Zhu, Jie Chen, Li Zhou, Xiaoyu Liang, Jiadi Lv, Roland Fiskesund, Yuying Liu & Bo Huang. (2018) Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells. Cancer Immunology Research 6:9, pages 1057-1068.
Crossref
Crossref
Hua Wang & David J. Mooney. (2018) Biomaterial-assisted targeted modulation of immune cells in cancer treatment. Nature Materials 17:9, pages 761-772.
Crossref
Crossref
Sepideh Parvizpour, Jafar Razmara & Yadollah Omidi. (2018) Breast cancer vaccination comes to age: impacts of bioinformatics. BioImpacts 8:3, pages 223-235.
Crossref
Crossref
Ling-xiao Zhang, Dong-qun Liu, Shao-wei Wang, Xiao-lin Yu, Mei Ji, Xi-xiu Xie, Shu-ying Liu & Rui-tian Liu. (2017) MgAl-layered double hydroxide nanoparticles co-delivering siIDO and Trp2 peptide effectively reduce IDO expression and induce cytotoxic T-lymphocyte responses against melanoma tumor in mice. Journal of Materials Chemistry B 5:31, pages 6266-6276.
Crossref
Crossref
Dabing Xue, Ying Liang, Siliang Duan, Jian He, Jing Su, Jianmeng Zhu, Nan Hu, Jianming Liu, Yongxiang Zhao & Xiaoling Lu. (2016) Enhanced anti-tumor immunity against breast cancer induced by whole tumor cell vaccines genetically modified expressing α-Gal epitopes. Oncology Reports 36:5, pages 2843-2851.
Crossref
Crossref
Huiting Su, Bing Li, Lan Zheng, Haixia Wang & Liping Zhang. (2016) Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma. Oncotarget 7:30, pages 48401-48411.
Crossref
Crossref
Haiyan Xu, Jie Meng, Qiang Ma & Xiaojin Li. 2016. Biomedical Applications and Toxicology of Carbon Nanomaterials. Biomedical Applications and Toxicology of Carbon Nanomaterials
357
396
.
Joanna Marczynska, Magdalena Banas, Krzysztof Guzik, Michal Koltun, Pawel Majewski, Joanna Cichy, Martyna Krzykawska-Serda, Anna Makarska & Mateusz Kwitniewski. (2015) Chlorin e6-mediated photodynamic effect diminishes therapeutic potential of 5-aza-2?-deoxycytidine-based whole-tumour-cell vaccine in mice bearing squamous cell carcinoma SCCVII. Journal of Photochemistry and Photobiology B: Biology 153, pages 455-462.
Crossref
Crossref
Meihua Chen, Rong Xiang, Yuan Wen, Guangchao Xu, Chunting Wang, Shuntao Luo, Tao Yin, Xiawei Wei, Bin Shao, Ning Liu, Fuchun Guo, Meng Li, Shuang Zhang, Minmin Li, Kexing Ren, Yongsheng Wang & Yuquan Wei. (2015) A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts. Scientific Reports 5:1.
Crossref
Crossref
Chien-Chiao Huang, Kung-Kai Kuo, Ta-Chun Cheng, Chih-Hung Chuang, Chien-Han Kao, Yuan-Chin Hsieh, Kuang-Hung Cheng, Jaw-Yuan Wang, Chiu-Min Cheng, Chien-Shu Chen & Tian-Lu Cheng. (2015) Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine. PLOS ONE 10:7, pages e0133470.
Crossref
Crossref
Bernadette D'Souza, Gary Bumgarner, Sucheta D'Sa, Tuhin Bhowmik, Periasamy Selvaraj & Martin D'Souza. 2015. Nanoparticulate Vaccine Delivery Systems. Nanoparticulate Vaccine Delivery Systems
157
170
.
Aurélien Lathuilière, Nicolas Mach & Bernard Schneider. (2015) Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System. International Journal of Molecular Sciences 16:12, pages 10578-10600.
Crossref
Crossref
Valeria Amenta & Karin Aschberger. (2014) Carbon nanotubes: potential medical applications and safety concerns. WIREs Nanomedicine and Nanobiotechnology 7:3, pages 371-386.
Crossref
Crossref
Feifan Zhou, Xiaosong Li, Mark F. Naylor, Tomas Hode, Robert E. Nordquist, Luciano Alleruzzo, Joseph Raker, Samuel S.K. Lam, Nan Du, Lei Shi, Xiuli Wang & Wei R. Chen. (2015) InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Letters 359:2, pages 169-177.
Crossref
Crossref
Huafeng Zhang, Ke Tang, Yi Zhang, Ruihua Ma, Jingwei Ma, Yong Li, Shunqun Luo, Xiaoyu Liang, Tiantian Ji, Zhichao Gu, Jinzhi Lu, Wei He, Xuetao Cao, Yonghong Wan & Bo Huang. (2015) Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling. Cancer Immunology Research 3:2, pages 196-205.
Crossref
Crossref
Shoiab Bukhari, Taseem A. Mokhdomi, Naveed A. Chikan, Asif Amin, Hilal Qazi, Sajad H. Wani, Asrar H. Wafai, Sumira Tyub, Farhat Mustafa, Masood S. Mir, Nisar A. Chowdri & Raies A. Qadri. (2015) Affinity proteomics led identification of vimentin as a potential biomarker in colon cancers: insights from serological screening and computational modelling. Molecular BioSystems 11:1, pages 159-169.
Crossref
Crossref
Liangran Guo, Daisy D. Yan, Dongfang Yang, Yajuan Li, Xiaodong Wang, Olivia Zalewski, Bingfang Yan & Wei Lu. (2014) Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles. ACS Nano 8:6, pages 5670-5681.
Crossref
Crossref
Chris Weir, Amanda L. Hudson, Elizabeth Moon, Angus Ross, Miles Alexander, Lyndsay Peters, Veronika Langova, Stephen J. Clarke, Nick Pavlakis, Ross Davey & Viive M. Howell. (2014) Streptavidin: A Novel Immunostimulant for the Selection and Delivery of Autologous and Syngeneic Tumor Vaccines. Cancer Immunology Research 2:5, pages 469-479.
Crossref
Crossref
Min Liu, Qin Pan, Fengling Luo, Craig Meyers & Xiao-Lian Zhang. (2013) Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs. Wuhan University Journal of Natural Sciences 18:1, pages 1-8.
Crossref
Crossref
Kazuo Maruyama, Ryo Suzuki, Yusuke Oda, Yoko Endo‐Takahashi & Yoichi Negishi. 2013. Bio‐Nanotechnology. Bio‐Nanotechnology
227
245
.
Yanlin Wang. (2012) Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses. Oncology Reports.
Crossref
Crossref
Jeffrey C. Gildersleeve, Baomei Wang, Samuel Achilefu, Zhude Tu & Mai Xu. (2012) Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies. Bioorganic & Medicinal Chemistry Letters 22:22, pages 6839-6843.
Crossref
Crossref
Yusuke Oda, Ryo Suzuki, Shota Otake, Norihito Nishiie, Keiichi Hirata, Risa Koshima, Tetsuya Nomura, Naoki Utoguchi, Nobuki Kudo, Katsuro Tachibana & Kazuo Maruyama. (2012) Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis. Journal of Controlled Release 160:2, pages 362-366.
Crossref
Crossref
Elena E. Balashova, Maxim I. Dashtiev & Petr G. Lokhov. (2012) Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence. Molecular & Cellular Proteomics 11:2, pages M111.014480.
Crossref
Crossref
Hidekazu Shirota & Dennis M. Klinman. (2011) CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity. Cancer Immunology, Immunotherapy 60:5, pages 659-669.
Crossref
Crossref
Zhao Sun, Wei Wang, Rui Wang, Jinhong Duan, Yan Hu, Jin Ma, Jiayan Zhou, Sishen Xie, Xin Lu, Zhaohui Zhu, Shuchang Chen, Yuanli Zhao, Haiyan Xu, Chen Wang & Xian-Da Yang. (2010) Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine. Cancer Nanotechnology 1:1-6, pages 63-69.
Crossref
Crossref
HaiYan Xu, Jie Meng & Hua Kong. (2010) What are carbon nanotubes’ roles in anti-tumor therapies?. Science China Chemistry 53:11, pages 2250-2256.
Crossref
Crossref
Matteo Vergati, Chiara Intrivici, Ngar-Yee Huen, Jeffrey Schlom & Kwong Y. Tsang. (2010) Strategies for Cancer Vaccine Development. Journal of Biomedicine and Biotechnology 2010, pages 1-13.
Crossref
Crossref
W M Liu, D W Fowler, P Smith & A G Dalgleish. (2009) Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. British Journal of Cancer 102:1, pages 115-123.
Crossref
Crossref
Mladen Korbelik. 2010. Photodynamic Therapy. Photodynamic Therapy
147
153
.
Michael G. LaCelle, Shawn M. Jensen & Bernard A. Fox. (2009) Partial CD4 Depletion Reduces Regulatory T Cells Induced by Multiple Vaccinations and Restores Therapeutic Efficacy. Clinical Cancer Research 15:22, pages 6881-6890.
Crossref
Crossref
Evelien L.J.M. SmitsSébastien AnguilleNathalie CoolsZwi N. BernemanViggo F.I. Van Tendeloo. (2009) Dendritic Cell-Based Cancer Gene Therapy. Human Gene Therapy 20:10, pages 1106-1118.
Crossref
Crossref
John Copier & Angus Dalgleish. 2009. Tumor‐Associated Antigens. Tumor‐Associated Antigens
281
302
.
Ryo Suzuki, Yusuke Oda, Naoki Utoguchi, Eisuke Namai, Yuichiro Taira, Naoki Okada, Norimitsu Kadowaki, Tetsuya Kodama, Katsuro Tachibana & Kazuo Maruyama. (2009) A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. Journal of Controlled Release 133:3, pages 198-205.
Crossref
Crossref
Gianpiero Gravante, Giuseppe Sconocchia, Seok Ling Ong, Ashley R. Dennison & David M. Lloyd. (2009) Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver International 29:1, pages 18-24.
Crossref
Crossref
Therese Buskas, Pamela Thompson & Geert-Jan Boons. (2009) Immunotherapy for cancer: synthetic carbohydrate-based vaccines. Chemical Communications:36, pages 5335.
Crossref
Crossref
Joseph Lustgarten & Noweeda Mirza. 2009. Handbook on Immunosenescence. Handbook on Immunosenescence
1189
1216
.
Min Wang, Ryan S. Senger, Carlos Paredes, Gautam G. Banik, Andy Lin & Eleftherios T. Papoutsakis. (2009) Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: Scale-up of a whole-cell immunotherapy product. Biotechnology and Bioengineering, pages n/a-n/a.
Crossref
Crossref
Tae S. Kim, Byeong C. Lee, Eugene Kim, Daeho Cho & Edward P. Cohen. (2008) Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice. Vaccine 26:47, pages 5928-5934.
Crossref
Crossref
Jie Meng, Jie Meng, Jinhong Duan, Hua Kong, Li Li, Chen Wang, Sishen Xie, Shuchang Chen, Ning Gu, Haiyan Xu & Xian-Da Yang. (2008) Carbon Nanotubes Conjugated to Tumor Lysate Protein Enhance the Efficacy of an Antitumor Immunotherapy. Small 4:9, pages 1364-1370.
Crossref
Crossref
Qiang Zhou, Xiaocai Yan, Jill Gershan, Rimas J. Orentas & Bryon D. Johnson. (2008) Expression of Macrophage Migration Inhibitory Factor by Neuroblastoma Leads to the Inhibition of Antitumor T Cell Reactivity In Vivo. The Journal of Immunology 181:3, pages 1877-1886.
Crossref
Crossref
Hidemasa Tamai, Satoshi Watanabe, Rongxiu Zheng, Katsuya Deguchi, Peter A. Cohen, Gary K. Koski & Suyu Shu. (2008) Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic–tumor hybrid vaccination and adoptive transfer of sensitized T cells. Clinical Immunology 127:1, pages 66-77.
Crossref
Crossref
Jian-Qing Gao, Naoki Okada, Tadanori Mayumi & Shinsaku Nakagawa. (2007) Immune Cell Recruitment and Cell-Based System for Cancer Therapy. Pharmaceutical Research 25:4, pages 752-768.
Crossref
Crossref
Pierpaolo Correale, Maria Teresa Del Vecchio, Marco La Placa, Francesco Montagnani, Giuseppa Di Genova, Gianni Gori Savellini, Chiara Terrosi, Susanna Mannucci, Giorgio Giorgi, Guido Francini & Maria Grazia Cusi. (2008) Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs. Journal of Immunotherapy 31:2, pages 132-147.
Crossref
Crossref
Taek Joon YoonJi Yeon KimHyojeong KimChangwan HongHyunji LeeChang-Kwon LeeKwang Ho LeeSeokmann HongSe-Ho Park. (2008) Anti-tumor immunostimulatory effect of heat-killed tumor cells. Experimental and Molecular Medicine 40:1, pages 130.
Crossref
Crossref
W. Wang, Y. Hu, Z. Sun, J. H. Duan, S. C. Chen & Xian-Da Yang. 2008. 7th Asian-Pacific Conference on Medical and Biological Engineering. 7th Asian-Pacific Conference on Medical and Biological Engineering
202
205
.
Jürgen Scherer, Thomas Hinz & Klaus Cichutek. (2007) Trends in der Impfstoffentwicklung. DNA‐ und zellbasierte Impfstoffe. Pharmazie in unserer Zeit 37:1, pages 86-92.
Crossref
Crossref
Matthias T Stephan, Vladimir Ponomarev, Renier J Brentjens, Alex H Chang, Konstantin V Dobrenkov, Glenn Heller & Michel Sadelain. (2007) T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nature Medicine 13:12, pages 1440-1449.
Crossref
Crossref
M Korbelik, B Stott & J Sun. (2007) Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. British Journal of Cancer 97:10, pages 1381-1387.
Crossref
Crossref
Keisuke Matsuo, Tomoaki Yoshikawa, Atsushi Oda, Takami Akagi, Mitsuru Akashi, Yohei Mukai, Yasuo Yoshioka, Naoki Okada & Shinsaku Nakagawa. (2007) Efficient generation of antigen-specific cellular immunity by vaccination with poly(?-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides. Biochemical and Biophysical Research Communications 362:4, pages 1069-1072.
Crossref
Crossref
Lilah F. Morris & Antoni Ribas. (2007) Therapeutic Cancer Vaccines. Surgical Oncology Clinics of North America 16:4, pages 819-831.
Crossref
Crossref
John Copier, Stephen Ward & Angus Dalgleish. (2007) Cell based cancer vaccines: Regulatory and commercial development. Vaccine 25, pages B35-B46.
Crossref
Crossref